65136-51-8

Basic information

• Product Name: Benzoic acid, 4-(2-chloroethoxy)-
• CAS NO: 65136-51-8
• Molecular Formula: C9H9ClO3
• Molecular Weight: 200.622
• Mol File: 65136-51-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(2-chloroethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(2-chloroethoxy)-(65136-51-8)
• EPA Substance Registry System: Benzoic acid, 4-(2-chloroethoxy)-(65136-51-8)

Safety Data

• Hazardous Substances Data: 65136-51-8(Hazardous Substances Data)

Upstream product

• 99-76-3 methyl 4-hydroxylbenzoate 
• 107-04-0 1-Bromo-2-chloroethane 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 40992-21-0 4-(2-chloro-ethoxy)-benzoic acid ethyl ester 
• 624-70-4 1-chloro-2-iodoethane 
• 38567-00-9 4-(2-Chloroethoxy)benzoic acid methyl ester 
• 622-86-6 2-chloroethoxybenzene 
• 3204-73-7 4-(2-hydroxyethoxy)benzoic acid methyl ester 
• 1711-24-6 4-(2-hydroxyethoxy)benzoic acid 
• 99847-87-7 1-(2-chloroethoxy)-4-(chloromethyl)benzene 
• 65136-50-7 4-(2-chloro-ethoxy)-benzoyl chloride 

Downstream Products

• 65136-50-7 4-(2-chloro-ethoxy)-benzoyl chloride 
• 84541-38-8 [6-Methoxy-2-(4-Methoxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-Piperidinyl)ethoxy]phenyl] Methanone 
• 84449-90-1 Raloxifen 
• 1622206-03-4 C₂₅H₂₃ClN₄O₅ 
• 1622204-11-8 5-((2-(4-(2-(4-hydroxypiperidin-1-yl)ethoxy)benzamide)pyridin-4-yl)oxy)-6-methoxy-N-methyl-1H-indole-1-carboxamide 

Relevant articles and documents

Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment

To address the multifactorial nature of Alzheimer's Disease (AD), a multi-target-directed ligand approach was herein developed. As a follow-up of our previous studies, a small library of newly designed 2-arylbenzofuran derivatives was evaluated towards ch

MONOCYCLIC PYRIDINE DERIVATIVE

The present invention provides a novel compound having FGFR inhibitory activity or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same. Specifically, the present invention provides a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or —CH2—; E represents a nitrogen-containing non-aromatic heterocycle; R1 represents an alkoxy group or the like; R2 represents a hydrogen atom or the like; and R3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like, with the proviso that when E represents an azetidine ring and R2 or R3 is present on a nitrogen atom on the azetidine ring, the R2 or R3 does not represent a hydrogen atom.

Benzothiophenes and related compounds as estrogen agonists

The invention is a compound of Formula (I): wherein R is —OH, R1is —OH, R2is —H, n is 2 or 3 and X is sulfur, or a pharmaceutically acceptable salt of a compound having Formula (1), or a pharmaceutical composition comprising a compou